Myelosafe Capsule Substitute
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
Composition:
LENALIDOMIDE-10MG
Uses:
Multiple myeloma, myelodysplastic syndromes, mantle cell lymphoma, and follicular lymphoma.
Medicinal Benefits:
Myelosafe Capsule belongs to the group of medicines called immunomodulatory agents. Myelosafe Capsule is used to treat multiple myeloma, myelodysplastic syndromes, mantle cell lymphoma, and follicular lymphoma. Myelosafe Capsule works by helping the body’s immune system and directly attacks cancer. It stops the development of cancer cells, stops the blood vessels growing in cancer, and stimulates the part of the immune system to attack the cancer cells. Myelosafe Capsule kills the abnormal cells in the bone marrow and helps the bone marrow to produce normal blood cells. Myelosafe Capsule is used to treat a type of myelodysplastic syndromes (MDS) known as deletion 5q MDS, where part of chromosome 5 is missing.
Myelosafe Capsule works by helping the body’s immune system and directly attacks cancer. It stops the development of cancer cells, stops the blood vessels growing in cancer, and stimulates the part of the immune system to attack the cancer cells.
Do not stop taking Myelosafe Capsule on your own. You are advised to take Myelosafe Capsule for as long as your doctor has prescribed it for you, depending on your medical condition. Do not be reluctant to speak with your doctor if you experience any difficulty while taking Myelosafe Capsule .
No, it is not safe to father a child while taking Myelosafe Capsule . Myelosafe Capsule can pass into human semen. During sexual activity with females of reproductive potential, always use effective contraception such as latex or synthetic condom while taking Myelosafe Capsule and for at least 4weeks after discontinuing Myelosafe Capsule , even if you have undergone a successful vasectomy. Male patients taking Myelosafe Capsule must not donate semen whilst taking Myelosafe Capsule and for 4weeks after discontinuing Myelosafe Capsule .
Patients taking Myelosafe Capsule must not donate blood during the treatment with Myelosafe Capsule and for 1month after discontinuation of Myelosafe Capsule as the donated blood might be given to pregnant women whose foetus should not be exposed to Myelosafe Capsule since it causes severe birth defects.
People with multiple myeloma taking Myelosafe Capsule may have an increased risk for blood clots in veins, arteries, and lungs. The risk is even higher if you are taking dexamethasone with Myelosafe Capsule for treating multiple myeloma. Consult your doctor immediately if you notice symptoms such as shortness of breath, chest pain, and swelling in the legs or arm.
Myelosafe Capsule might cause neutropenia (low white blood cells) or thrombocytopenia (low platelets). Blood count should be checked regularly during treatment with Myelosafe Capsule .